TABLE 1.
Washington, DC (1 of 1 clinic) | Los Angeles (3 of 13 clinics) | San Diego (main clinic) | |
---|---|---|---|
Chlamydia trachomatis | |||
Positive/tested (%) | 149/2607 (5.7)* | 522/3764 (13.9)† | 131/2203 (5.9)† |
% Infected women presumptively treated | 91% | 79% | 69% |
Infected women requiring follow-up treatment, per month‡ | 1.1 | 9.3 | 3.4 |
Neisseria gonorrhoeae | |||
Positive/tested (%) | 151/2609 (5.8)* | 129/3917 (3.3)† | 27/2043 (1.3)† |
% Infected women presumptively treated | 93% | 58% | 63% |
Infected women requiring follow-up treatment per months‡ | 0.8 | 4.5 | 0.8 |
Testing performed with DNA probe test.
Testing performed with nucleic acid amplification test.
Women coinfected with C trachomatis and N gonorrhoeae were included in both study groups.